Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Neoplasm recurrence
ADR ID BADD_A06002
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.02      Neoplasms unspecified malignancy and site unspecified NEC
16.16.02.004      Neoplasm recurrence
Description Not Available
MedDRA Code 10061864
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Neoplasm recurrence NOS | Neoplasm recurrence
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00047Afatinib0.000112%
BADD_D00142Anastrozole0.000159%
BADD_D00193Axitinib0.000168%
BADD_D00286Bosutinib0.000112%
BADD_D00305Bromocriptine mesylate--
BADD_D00306Budesonide0.000140%
BADD_D00312Bupropion0.000018%
BADD_D00349Capecitabine0.000246%
BADD_D00364Carboplatin0.000336%
BADD_D00371Carmustine--
BADD_D00535Crizotinib0.000246%
BADD_D00551Cyclosporine0.000243%
BADD_D00560Cytarabine0.000224%
BADD_D00589Dasatinib0.000246%
BADD_D00623Dexamethasone0.000145%
BADD_D00723Doxorubicin0.000302%
BADD_D00809Escitalopram0.000076%
BADD_D00854Etoposide0.000112%
BADD_D00858Everolimus0.000489%
BADD_D00861Exemestane0.009411%
BADD_D00932Fluoxetine0.000030%
BADD_D00978Fulvestrant0.000334%
BADD_D01136Imatinib0.002574%
BADD_D01257Letrozole0.000263%
BADD_D01285Levothyroxine--
BADD_D01418Methotrexate0.000171%
BADD_D01478Mitomycin0.000112%
BADD_D01506Muromonab-cd3--
BADD_D01567Nilotinib0.000168%
BADD_D01633Oxaliplatin0.000168%
The 1th Page    1 2    Next   Last    Total 2 Pages